Document is current
Any future updates will be listed below
-
Authors
Stip, Marjolein C. https://orcid.org/0000-0002-5667-3402
Jansen, J. H. Marco
Nederend, Maaike
Tsioumpekou, Maria
Evers, Mitchell https://orcid.org/0000-0002-2940-5496
Olofsen, Patricia A. https://orcid.org/0000-0002-6100-9290
Meyer-Wentrup, Friederike
Leusen, Jeanette H. W. https://orcid.org/0000-0003-4982-6914
-
Funding
Funding for this research was provided by:
Villa Joep (project 17 IgA and anti-GD2, project 17 IgA and anti-GD2)
KWF Kankerbestrijding (9038 / 2021-PPS, 9038 / 2021-PPS, 9038 / 2021-PPS, 9038 / 2021-PPS)
- License Information
-
More Information
Article History
Received: 2 May 2023
Accepted: 7 June 2023
First Online: 20 June 2023
Declarations
:
: JHWL is co-founder of TigaTx and inventor on patent applications WO2019059771 and WO2020197400.
: All mouse experimental procedures were approved by the institute’s animal ethics committee and by the Dutch Central Authority for Scientific Procedures on Animals (CCD, AVD115002016410 and AVD11500202115442). The UNICIT patient cohort was established according to the declaration of Helsinki and approved by the UMC Utrecht ethics committee (biobank approval TCBio 18–123).
: All human research participants provided informed consent for publication of the data in Fig. E.
